Drug Safety Information for ERGOMAR (Ergotamine tartrate)

Adverse Drug Reactions for ERGOMAR* (Ergotamine tartrate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with ERGOMAR
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Drug interaction17
2Ergot poisoning10
3Cyanosis10
4Chest pain9
5Nausea*8
6Dyspnoea8
7Vomiting8
8Pulse absent7
9Headache7
10Vasospasm7
11Pain7
12Hypertension6
13Muscle spasms6
14Pain in extremity6
15Blood pressure increased6
16Dizziness6
17Migraine6
18Hypotension5
19Diarrhoea5
20Heart rate increased5

* This side effect also appears in "Top 10 Side Effects of ERGOMAR " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking ERGOMAR
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Migraine*133
2Headache128
3Product used for unknown indication13
4Cluster headache11
5Pain6

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for ERGOMAR

Total Reports Filed with FDA: 645


Number of FDA Adverse Event Reports by Patient Age for ERGOMAR

Total Reports Filed with FDA: 645*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Ergotamine tartrate (Medihaler ergotamine, Ergostat, Wigrettes, Ergotamine tartrate, Ergotamina, Ergomar)

Charts are based on 645 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and ERGOMAR Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.